Logifin CL 1% Lotion contains Luliconazole 1% w/v, an imidazole antifungal agent indicated for the topical treatment of superficial fungal infections such as dermatophytosis, candidiasis, and pityriasis versicolor. Luliconazole exhibits potent antifungal activity by inhibiting the biosynthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The lotion formulation facilitates easy application and rapid absorption into the affected skin areas, ensuring effective local drug delivery. Logifin CL 1% Lotion is typically applied once daily to the affected area and surrounding skin after thorough cleansing and drying, with the duration of therapy varying according to the severity and type of infection, generally ranging from 1 to 4 weeks. It is well tolerated with minimal adverse effects, which may include mild local irritation, burning, or itching at the application site. Caution is advised in patients with known hypersensitivity to luliconazole or other azole antifungals. This product is contraindicated for use on mucous membranes or open wounds. Logifin CL 1% Lotion offers an effective and convenient treatment option for managing superficial fungal infections, promoting resolution of symptoms and preventing recurrence when used as directed.